Migraine and episodic Vertigo: a cohort survey study of their relationship.

J Headache Pain

Headache Medical Centre, Linz, Ordensklinikum Linz Barmherzige Schwestern, 4020, Linz, Austria.

Published: April 2019

Background And Aim: Migraine headache and vestibular-type vertigo co-occur in the general population about three times more often than expected by chance. Attacks of episodic vertigo (eV) are currently not recognized as migraine equivalents or variants in the International Classification of Headache Disorders, 3rd edition (ICHD III). No strong data exist about the prevalence of eV during the phases of a migraine attack. The aim of this study is to analyze the timing association between migraine-related episodic vertigo and the phases of migraine.

Methods: The "Migraine and Neck Pain Study" gathered data from nearly 500 adult participants in a questionnaire-based survey. In this prospective, follow-up study we re-analyzed patients with episodic migraine with and without aura who experienced eV anytime around their migraine attacks. For this we defined 3 different time periods.

Results: 146/487 (30%) reported eV anytime during the migraine attack; 79/487 (16%) that noticed eV with the start of the headache, 51/487 (10%) within 2 h before the headache and 16/487 (3%) experienced eV 2-48 h before the headache, as a premonitory symptom. 130/487 (26.7%) of our patients can be diagnosed with vestibular or probable vestibular migraine supporting the clinical association of migraine and vertigo.

Conclusions: Our results seem to further support the concept that vertigo in migraine is best thought of as an integral manifestation of migraine, rather than a prodromal or aura symptom.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734421PMC
http://dx.doi.org/10.1186/s10194-019-0991-2DOI Listing

Publication Analysis

Top Keywords

episodic vertigo
12
migraine
11
migraine attack
8
anytime migraine
8
vertigo
5
headache
5
migraine episodic
4
vertigo cohort
4
cohort survey
4
survey study
4

Similar Publications

Background: Vertigo is a priority for training and decision support in emergency departments (ED). Benign paroxysmal positional vertigo (BPPV), though manageable at bedside, remains frequently underdiagnosed and undertreated. This study assessed the effectiveness of a two-tiered educational intervention on posterior and horizontal BPPV management in the ED setting.

View Article and Find Full Text PDF

Acute vertigo or dizziness is a frequent presentation to the emergency department (ED), making up between 2.1% and 4.4% of all consultations.

View Article and Find Full Text PDF

Background And Purpose: Vestibular migraine (VM) is a common clinical disorder with a genetic predisposition characterized by recurrent episodes of dizziness/vertigo. Patients often complain of the presence of cognitive dysfunction manifestations such as memory loss, which causes great distress in daily life. In this study, we will explore the characteristics and possible risk factors of VM-related cognitive dysfunction by observing the cognitive function and vestibular function status of VM patients, laying the foundation for further exploration of the mechanisms of VM-related cognitive dysfunction.

View Article and Find Full Text PDF
Article Synopsis
  • Benign paroxysmal positional vertigo (BPPV) causes recurring episodes of vertigo, and despite initial symptom resolution, many patients experience relapses and other complications such as migraines, neck pain, and falls after discharge.
  • This study observed 124 patients with BPPV and found that 70.97% of them reported new symptoms post-treatment, with prior neck pain, headaches, and migraines being significant predictors for future issues.
  • Key findings highlight that low vitamin D levels may increase recurrence risk, and the relationship between anxiety and persistent postural-perceptual dizziness (PPPD) suggests that BPPV is often accompanied by lingering symptoms despite the absence of nystagmus.
View Article and Find Full Text PDF

Objective: To evaluate the plasma levels of the otoconial proteins, otoconin-90 and otolin-1, in individuals diagnosed with vestibular neuritis (VN) and determine the feasibility of using these proteins as biomarkers for VN.

Methods: In this preliminary study, 30 patients diagnosed with VN and 70 healthy individuals were recruited and followed to confirm whether they had benign paroxysmal positional vertigo (BPPV) during the following time. The recorded data included measurements of height, weight, and history of diabetes mellitus or hypertension.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!